Inventor
LYNCH JOSEPH E
US20 patents
⚠️ This page may combine multiple inventors who share the name “LYNCH JOSEPH E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
17 patentsUS5290941AMar 1, 1994
Facile condensation of methylbenzoxazoles with aromatic aldehydes
MERCK & CO INC45 citations91
US5723616AMar 3, 1998
Process for the preparation of a growth hormone secretagogue
MERCK & CO INC24 citations88
US6143885ANov 7, 2000
Preparation of beta-methyl carbapenem intermediates
MERCK & CO INC18 citations84
US5919937AJul 6, 1999
Process for phosphodiesterase IV inhibitors
MERCK & CO INC16 citations72
US6355611B1Mar 12, 2002
Salt form of a conjugate useful in the treatment of prostate cancer
MERCK & CO INC7 citations71
US5493018AFeb 20, 1996
Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid
MERCK & CO INC7 citations68
US4611081ASep 9, 1986
Process for the preparation of HMG-CoA reductase inhibitors intermediates
MERCK & CO INC5 citations63
US4952288AAug 28, 1990
Process for the preparation of 4-acyloxyazetidin-2-one by electrochemical methods
MERCK & CO INC5 citations62
US4940520AJul 10, 1990
Process for the preparation of 4-acyloxyazetidin-2-one by singlet oxygen oxidation
MERCK & CO INC5 citations62
US4923982AMay 8, 1990
Oxidation and reduction method to produce 4-acyloxyazetidin-2-one
MERCK & CO INC3 citations62
US5922906AJul 13, 1999
Side chains synthesis for an anthiarrhythmic compound
MERCK & CO INC2 citations61
US5380849AJan 10, 1995
Process for optically pure decahydroisoqiunolines
MERCK & CO INC2 citations60
US5808082ASep 15, 1998
Method of preparing phosphodiesterase IV inhibitors
MERCK & CO INC2 citations59
US5177201AJan 5, 1993
Nitrogen deprotected 4-acyloxyazetidin-2-ones
MERCK & CO INC1 citations51
US5777123AJul 7, 1998
Process for regioselective substitution of trifluorobenzoate or trifluorobenzonitrile
MERCK & CO INC0 citations50
US5145957ASep 8, 1992
Stereoselective synthesis of a chiral cis 3-beta hydrogen (3R) 4-aroyloxy azetidinone
MERCK & CO INC0 citations41
US6552166B1Apr 22, 2003
Process for the preparation of conjugates useful in the treatment of prostate cancer
MERCK & CO INC0 citations38